The findings of Gavins et al. implicated that FPR ligands, particularly in the brain, could be novel and exciting anti-inflammatory therapeutics for the treatment of a variety of clinical conditions, including stroke [35]. This evidence concerns the gene FPR1 and stroke disorder.